RAM
TNGX icon

Readystate Asset Management’s Tango Therapeutics TNGX Stock Holding History

Readystate Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-245,109
Closed -$2.06M – 473
2025
Q3 		$2.06M Sell
245,109
-173,408
-41% -$1.17M 0.09% 147
2025
Q2 		$2.14M Buy
+418,517
New +$1.03M 0.07% 155
2024
Q2 		– Sell
-168,400
Closed -$1.34M – 1078
2024
Q1 		$1.34M Buy
+168,400
New +$1.81M 0.02% 650

Other funds holding TNGX

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Readystate Asset Management's TNGX Position: Q4 2025 in Review

Readystate Asset Management sold out of Tango Therapeutics (TNGX) in Q4 2025, closing a stake of 245,109 shares — an estimated $2.06M sold.

Readystate Asset Management first reported a position in TNGX in Q1 2024 and held it in 3 quarters. The position peaked at $2.14M in Q2 2025. 170 funds tracked by Wall St. Rank hold TNGX as of Q4 2025.

  • Readystate Asset Management reported no remaining Tango Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Readystate Asset Management sold 245,109 Tango Therapeutics shares in Q4 2025, an estimated $2.06M.
  • Readystate Asset Management first reported a position in Tango Therapeutics in Q1 2024 and held it in 3 quarters.
  • Readystate Asset Management's Tango Therapeutics position peaked at $2.14M in Q2 2025.
  • 170 funds tracked by Wall St. Rank held Tango Therapeutics as of Q4 2025.

Based on Readystate Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.